Bluesky Facebook Reddit Email

Treating hereditary retinal degeneration

03.12.18 | Proceedings of the National Academy of Sciences

Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Researchers report that administration of a nanosized liposomal formulation containing an analog of the signaling molecule cGMP helped reduce rod photoreceptor loss and restore retinal function in three different rodent models of hereditary retinal degeneration, a neurodegenerative condition that leads to loss of photoreceptors and blindness and that lacks effective treatments.

###

Article #17-18792: "Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration," by Eleonora Vighi et al.

MEDIA CONTACT: Francois Paquet-Durand, University of Tuebingen, GERMANY; tel: +49 7071 29 87430, 0+49 162 238 3255; e-mail: < francois.paquet-durand@klinikum.uni-tuebingen.de >

Proceedings of the National Academy of Sciences

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
Proceedings of the National Academy of Sciences. (2018, March 12). Treating hereditary retinal degeneration. Brightsurf News. https://www.brightsurf.com/news/L3YWP7E1/treating-hereditary-retinal-degeneration.html
MLA:
"Treating hereditary retinal degeneration." Brightsurf News, Mar. 12 2018, https://www.brightsurf.com/news/L3YWP7E1/treating-hereditary-retinal-degeneration.html.